It must not be consumed, injected, applied topically, or used outside of a controlled research setting
They also estimated the hormone secretion during this period
The purpose of this review is to summarise the physiological effects as well as the therapeutic implications of the gut hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin, peptide YY (PYY), and glucose-dependent insulinotropic peptide (GIP) in the treatment of obesity and type 2 diabetes
[DOI] [PubMed] [Google Scholar] 75.Heerspink HJL, et al
For organizations studying GLP-1 therapies, that means richer longitudinal patient journeys, broader population coverage and greater confidence in understanding prescribing patterns, treatment persistence, clinical outcomes and market dynamics
doi: 10.2174/1570159X18666200528142429 31 AlberdiEWyssenbachAAlberdiMSnchez-GmezMVCavaliereFRodrguezJJet al